DI SOMMA, MARGHERITA
 Distribuzione geografica
Continente #
NA - Nord America 575
EU - Europa 394
AS - Asia 127
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 1.099
Nazione #
US - Stati Uniti d'America 572
PL - Polonia 160
CN - Cina 81
UA - Ucraina 60
IT - Italia 59
DE - Germania 22
FI - Finlandia 19
HK - Hong Kong 18
BE - Belgio 16
GB - Regno Unito 16
IE - Irlanda 12
SG - Singapore 10
VN - Vietnam 10
CZ - Repubblica Ceca 8
FR - Francia 6
NL - Olanda 6
IN - India 4
NO - Norvegia 4
CA - Canada 3
GR - Grecia 3
JP - Giappone 3
EU - Europa 2
ES - Italia 1
KR - Corea 1
LV - Lettonia 1
RO - Romania 1
ZA - Sudafrica 1
Totale 1.099
Città #
Warsaw 160
Ann Arbor 68
Fairfield 65
Ashburn 60
Jacksonville 53
Woodbridge 43
Seattle 37
Brescia 30
Dearborn 30
Cambridge 25
Chandler 24
Princeton 24
Wilmington 24
Houston 20
Helsinki 18
Hong Kong 18
Brussels 15
Nanjing 14
Beijing 13
New York 13
Dublin 12
Dong Ket 10
Shanghai 8
Des Moines 7
Amsterdam 6
Brno 6
Padova 6
Shenyang 6
Boardman 5
San Diego 5
Singapore 5
Jiaxing 4
Jinan 4
Nanchang 4
Stavanger 4
Tianjin 4
Changsha 3
Guangzhou 3
Hefei 3
Kunming 3
San Francisco 3
Washington 3
Zhengzhou 3
Hebei 2
Kilburn 2
Leawood 2
Napoli 2
Olomouc 2
Toronto 2
Bari 1
Bologna 1
Changchun 1
Chengdu 1
Cocquio Trevisago 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Kempton Park 1
L'aquila 1
Lanzhou 1
Larissa 1
Liège 1
London 1
Los Angeles 1
Madrid 1
Milan 1
Munich 1
Norwalk 1
Phoenix 1
Riga 1
San Giovanni Rotondo 1
San Mateo 1
Saronno 1
Tokyo 1
Tower Hamlets 1
Verona 1
Totale 910
Nome #
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 217
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 130
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo 125
High sulfation and a high molecular weight are important for anti-hepcidin activity of heparin 119
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 93
Evaluation of Paracellular Permeability in VEGFR2 Mutants Patient-Derived Organoid 80
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 73
Role of VEGFs in metabolic disorders 71
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 65
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 58
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 58
Identification and characterization of pro-oncogenic low frequency VEGFR2 mutations 49
Totale 1.138
Categoria #
all - tutte 4.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020364 29 15 10 20 23 55 53 52 33 33 20 21
2020/2021263 9 19 7 28 28 30 20 24 27 32 22 17
2021/2022116 9 17 1 8 3 7 5 7 4 19 11 25
2022/202390 13 6 4 5 6 25 0 5 17 0 3 6
2023/2024148 10 4 14 18 6 27 7 19 23 3 1 16
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.138